Preliminary data on WTX-124 provide compelling early evidence of dose-dependent biomarker and antitumor activity in patients with advanced or metastatic solid tumors relapsed or refractory to standard ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback